Skip to main content

ALL Specialities ALL Specialities

/

Endocrinology

Error message

Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

Conference Coverage

EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetes

Publish date: October 1, 2015

AT EASD 2015

References

The potential for alirocumab to reduce cardiovascular events will be investigated in the large, phase III ODYSSEY Outcomes study. This trial is currently recruiting and aims to accrue around 18,000 high-risk patients including those with diabetes. The study is projected to complete by the end of 2017.

Pages

« first
1
2

References

Recommended Reading

EASD: Pre-pregnancy weight, not gestational gain, affects later diabetes risk

MDedge Endocrinology

Long-acting insulin degludec – and degludec combo drug – win FDA nod

MDedge Endocrinology

ICAAC: 2015 brings three major systematic reviews of diabetic foot infection therapy

MDedge Endocrinology

Metformin associated with small height gain in children

MDedge Endocrinology

Evidence links common endocrine-disrupting chemicals to obesity, diabetes, reproductive disorders

MDedge Endocrinology

ADA proposes new standards for students with diabetes

MDedge Endocrinology

Severity of obesity matters in pediatric population

MDedge Endocrinology

EASD: Liraglutide lowers HbA1c when added to insulin in longstanding type 2 diabetes

MDedge Endocrinology

EASD: Metformin-induced B12 deficiency linked to diabetic neuropathy

MDedge Endocrinology

EASD: Diabetes doubles death risk from many causes

MDedge Endocrinology

Diabetes
Lipid Disorders

This Publication

About Us
Advertise
Contact Us
Corporate Management
Customer Service
Editorial Advisory Board
Editorial Staff
Subscribe To Clinical Endocrinology News

Facebook
Twitter

Specialty Focus

Men's Health
Diabetes
Pituitary, Thyroid & Adrenal Disorders
Endocrine Cancer
Menopause

Top Sections

Commentary
Law & Medicine

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

All Specialties